EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance

Wanqi Wang, Noor A Lokman, Simon C Barry, Martin K Oehler, Carmela Ricciardelli

Cancer and Metastasis Reviews · 2025

DOI: 10.1007/s10555-024-10239-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, 2025. Verfasst von Wanqi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, The University of Adelaide, Adelaide, 5005, Australia. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Adelaide.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells play an important role in tumor progression and chemotherapy resistance. Leucine-rich G repeat-containing protein-coupled receptor 5 (LGR5) has been identified as a cancer stem cell marker in several cancer types. LGR5 is involved in cancer development and progression via several pathways including WNT/β-catenin signaling pathway. LGR5 plays a role in tumor progression by promoting cancer cell migration, invasion, metastasis, and angiogenesis in many cancers including colorectal, brain, gastric, and ovarian cancer. This review summarises the current knowledge on the expression and functional role of LGR5 in cancers, the molecular mechanisms regulated by LGR5, and the relationship between LGR5 and chemotherapy resistance. The review also includes highlights potential strategies to inhibit LGR5 expression and function. The majority of functional studies have shown that LGR5 plays an important role in promoting cancer progression, metastasis and chemotherapy resistance however, in some contexts LGR5 can also activate tumor-suppressive pathways and LGR5 negative cells can also promote cancer progression. The review highlights that targeting LGR5 is a promising anti-cancer treatment but the functional effect of LGR5 on tumor cells is complex may be dependent on cancer type, tumor microenvironment and cross-talk with other molecules in the LGR5 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDrug Resistance, NeoplasmNeoplasmsHumansNeoplasm MetastasisAnimalsAntineoplastic AgentsNeoplastic Stem CellsMolecular Targeted Therapy

Stichwörter der Autor:innen

ChemoresistantLGR5MetastasisWNT/β-catenin

Substanzen

Receptors, G-Protein-CoupledLGR5 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, The University of Adelaide, Adelaide, 5005, Australia.
  • Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, 5005, Australia.
  • Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, 5000, Australia.
  • Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, The University of Adelaide, Adelaide, 5005, Australia. carmela.ricciardelli@adelaide.edu.au.

Förderung

  • The University of Adelaide

Zitieren

APA

Wang, W., Lokman, N. A., Barry, S. C., Oehler, M. K., & Ricciardelli, C. (2025). LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-024-10239-x

Vancouver

Wang W, Lokman NA, Barry SC, Oehler MK, Ricciardelli C. LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance. Cancer and Metastasis Reviews. 2025. doi:10.1007/s10555-024-10239-x

BibTeX
@article{Wang2025,
  author = {Wang, Wanqi and Lokman, Noor A and Barry, Simon C and Oehler, Martin K and Ricciardelli, Carmela},
  title = {LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance},
  journal = {Cancer and Metastasis Reviews},
  year = {2025},
  doi = {10.1007/s10555-024-10239-x}
}
Kostenlos starten →